Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading VERU INC. chart...

About the Company

We do not have any company description for VERU INC. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

72

Exchange

Nasdaq

$15M

Total Revenue

72

Employees

$193M

Market Capitalization

-3.26

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VERU News

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

20h ago, source:

About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The Company’s drug ...

Veru (VERU) Price Target Decreased by 15.38% to 2.81

8d ago, source: Fintel on MSN

The average one-year price target for Veru (NasdaqCM:VERU) has been revised to 2.80 / share. This is an decrease of 15.38% ...

Veru Inc (VERU) Stock: A Look at the Analyst Recommendations

11d ago, source: newsheater

To put it simply, Veru Inc (VERU) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth ...

3 Standout Penny Stocks to Watch This April

9d ago, source: Barchart on MSN

Investing in penny stocks \- generally, stocks that trade for less than $5 per share or have small market caps and low floats ...

Veru Inc (VERU) Volatility Hits 16.29% – Here Is What You Should Do

15d ago, source:

Veru Inc (NASDAQ:VERU) concluded the trading at $1.24 Wednesday, April 10, with a rise of 5.98% from its closing price on previous day. Taking a look at stock we notice that its last check on previous ...

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

on MSN ago, source:

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new ...

Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday

10d ago, source: Benzinga.com on MSN

Wedbush raised PVH Corp. PVH price target from $113 to $128. Wedbush analyst Tom Nikic upgraded the stock from Neutral to ...

COVID-19 Drug Pipeline Landscape Report 2024: Comprehensive Insights on 400+ Companies and 400+ Pipeline Drugs

10d ago, source:

Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "COVID-19 - Pipeline Insight, 2024," report provides comprehensive insights about 400+ companies and ...

World Metastatic Prostate Cancer Drug Landscape Research Report 2024: Comprehensive Insights about 90+ Companies and 110+ Pipeline Drugs

7d ago, source:

The "Metastatic Prostate Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 90+ companies and 110+ ...

NRx Pharmaceuticals: New Data Demonstrates No Impact Of NRX-101 On Gut Or Vaginal Flora

8d ago, source:

NRx Pharmaceuticals, Inc. (NRXP) reported new data that demonstrate that in a rodent model NRX-101 shows no measurable damage to ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...